]>
IRCT20141209020258N63 IRCT 2018-01-22 Arak University of Medical Sciences The Effects of Filgrastim on Prognosis of Patients with acute Ischemic Stroke The Effects of Filgrastim on Prognosis of Patients with acute Ischemic Stroke 2016-06-19 anticipated 84 Complete https://irct.ir/trial/28961 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: simple randomization with random numbers, Blinding description: The patient is not aware of the treatment received.Participant and Analyzer are blind (double blind). 2-3 acute Ischemic Stroke. Intervention 1: Intervention group: We treat patients(42 person) by 150 milligram in 24 hours Filgrastim in 3 ‎days in intervention group. Intervention 2: Control group: We treat patients(42 person) 150 milligram in 24 hours normal salin in control ‎group. Yes - There is a plan to make this available What will be shared: When we publish article in journal. When: After the article is published To whom: researcher in university Conditions: If there are additional questions Where to obtain: Dr Ebrahimi Monfared How to obtain: They have to write letters to the professors and the university. Comments:
public Dr Morteza Gharibi
Valiasr Hospital, Valiasr squre, Shahid Shirodi street
Arak Iran (Islamic Republic of) 3814957558 +98 86 3222 2003 gharibi@arakmu.ac.ir Arak University of Medical Sciences scientific Dr Mohsen Ebrahimimonfared
Valiasr Hospital, Valiasr squre, Shahid Shirodi street
Arak Iran (Islamic Republic of) 3814957558 +98 86 3222 2003 Ebrahimi@arakmu.ac.ir Arak University of Medical Sciences Iran (Islamic Republic of) 18 years and more Patients with acute ischemic stroke 18 years no limit Both Drinking alcohol and addict Incidence of side effects or the sensitivity of the drug History of blood pressure, diabetes, embolism and DVT Death of the patient 72 hours after entering the emergency room I63.9 Cerebral infarction, unspecified Treatment - Drugs Treatment - Drugs Intervention group: We treat patients(42 person) by 150 milligram in 24 hours Filgrastim in 3 ‎days in intervention group. Control group: We treat patients(42 person) 150 milligram in 24 hours normal salin in control ‎group. Hemoglobin. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: blood test. Power of the paraplegic organ. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: Physical examination. Awareness status. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: Glasgow Coma Scale. Motion status. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: Physical examination. Hematocrit. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: blood test. Arak University of Medical Sciences Approved 2016-06-13 Ethics committee Arak University Of Medical Sciences Vice chancellor for research, Payambar azam complex, Basij squre, Sardasht, Arak Arak Markazi Iran (Islamic Republic of)